𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues

✍ Scribed by M. J. Reed; G. W. Aherne; M. W. Ghilchik; S. Patel; J. Chakraborty

Publisher
John Wiley and Sons
Year
1991
Tongue
French
Weight
477 KB
Volume
49
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

4‐Hydroxyandrostenedione (4‐OHA) is a specific inhibitor of aromatase activity used for the treatment of breast cancer in post‐menopausal women. Treatment with 4‐OHA has been shown to inhibit the peripheral conversion of androstenedione to oestrone and reduce plasma oestrogen concentrations, but the effect of treatment on breast‐tissue oestrone concentrations is not known. We have therefore examined the effect of treatment with 4‐OHA on oestrone concentrations in normal and malignant breast tissues and also measured plasma and tissue 4‐OHA concentrations. Changes in tumour oestrone concentrations were related to DNA polymerase α activity, a marker of cellular proliferation. Blood and breast‐tissue samples were obtained before and 36 hr after treatment with 4‐OHA. The mean plasma concentration of 4‐OHA was 27.9 ± 19.3 ng/ml, compared with levels of 33.7 ± 25.6 ng/g for breast tumour and 13.5 ± 11.5 ng/g for normal breast tissue. There was a significant correlation between 4‐OHA concentrations in plasma and normal breast tissue (r = 0.91, p < 0.001). Treatment with 4‐OHA resulted in a significant (p < 0.02) decrease in breast‐tissue oestrone concentrations. For 3/4 tumour samples, a marked decrease in the concentration of oestrone (78 ± 4%) was associated with a similar decrease (64 ± 16%) in DNA polymerase α activity. It is concluded that treatment with 4‐OHA effectively reduces breast‐tissue exposure to oestrogen.

📜 SIMILAR VOLUMES

Midkine and pleiotrophin expression in n
Midkine and pleiotrophin expression in normal and malignant breast tissue
✍ Robert I. Garver Jr.; Diane M. Radford; Helen Donis-Keller; Mark R. Wick; Peter 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 805 KB

Background. Some growth factors may promote tumor growth by affecting tumor angiogenesis. The angiogenic growth factor, pleiotrophin, was demonstrated previously in human breast carcinoma tissues; however, the pattern of pleiotrophin expression in normal breast tissues has not been established. Met

Study of FHIT transcripts in normal and
Study of FHIT transcripts in normal and malignant breast tissue
✍ Ivan Bièche; Alain Latil; Véronique Becette; Rosette Lidereau 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

Cytogenetic and molecular studies have suggested that the 3p14.2 chromosome subband contains tumor suppressor genes involved in the pathogenesis of many types of human cancers. Recently, the FHIT (fragile histidine triad) gene was identified in this part of chromosome 3 as a candidate suppressor gen

Discrimination of normal, benign, and ma
Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy
✍ M. V. P. Chowdary; K. Kalyan Kumar; Jacob Kurien; Stanley Mathew; C. Murali Kris 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 482 KB

## Abstract Breast cancers are the leading cancers among females. Diagnosis by fine needle aspiration cytology (FNAC) is the gold standard. The widely practiced screening method, mammography, suffers from high false positive results and repeated exposure to harmful ionizing radiation. As with all o

A comparison of the in vivo uptake and m
A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women
✍ J. M. McNeill; M. J. Reed; P. A. Beranek; R. C. Bonney; M. W. Ghilchik; D. J. Ro 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 426 KB

After infusion of 3H-oestradiol or 'H-oestrone into post-menopausal women with breast cancer, there was a significant uptake of both steroids by breast turnour and normal tissue. The ro ortion of oestrogen present in turnour tissue as H-oestradiol after infusion of 'H-oestradiol (89.4 f 3.5%, mean +

Expression of the receptor for parathyro
Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue
✍ Downey, Sarah E.; Hoyland, Judith; Freemont, Anthony J.; Knox, Fiona; Walls, Jan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 2 views

Parathyroid hormone-related protein (PTHrP) is the cause of humoral hypercalcaemia of malignancy and interacts with parathyroid hormone (PTH) receptors. Breast cancer cells produce PTHrP in vitro and in vivo. The breast cancer cell line MCF-7, which products PTHrP and expresses PTHrP receptors, prol

Differential immunohistochemical detecti
Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues
✍ Luigi Panico; Antonio D'Antonio; Gaetano Salvatore; Ernesto Mezza; Giampaolo Tor 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 782 KB

The expression of growth factors, such as transforming growth factor a (TGFa), amphiregulin (AR) and CRIPTO, a type-I tyrosine-kinase growth factor receptor (erbB-2), and a tumor-suppressor gene (p53). that have been implicated in the development and/or the progression of breast cancer, was evaluate